Surgical Endoscopy

, Volume 24, Issue 10, pp 2547–2555

Management of postgastric bypass noninsulinoma pancreatogenous hypoglycemia

  • Viney K. Mathavan
  • Maurice Arregui
  • Chad Davis
  • Kirpal Singh
  • Anand Patel
  • James Meacham



Postgastric bypass noninsulinoma hyperinsulinemic pancreatogenous hypoglycemia defines a group of patients with postprandial neuroglycopenic symptoms similar to insulinoma but in many cases more severe. There are few reports of patients with this condition. We describe our surgical experience for the management of this rare condition.


A retrospective study was performed at St. Vincent Hospital, Indianapolis. Fifteen patients were identified with symptomatic postgastric bypass hypoglycemia for the period 2004–2008. All patients were initially treated with medical therapy for hypoglycemia. Nine patients eventually underwent surgical treatment. The preoperative workup included triple-phase contrast CT scan of the abdomen, endoscopic ultrasound of the pancreas, a 72-h fast followed by a mixed meal test, and calcium-stimulated selective arteriography. Intraoperative pancreatic ultrasound also was performed in all patients. Patients then underwent thorough abdominal exploration, exploration of the entire pancreas, and extended distal pancreatectomy.


Nine patients underwent surgery. The mean duration of symptoms was 14 months. The 72-h fast was negative in eight patients (as expected). Triple-phase contrast CT scan of the abdomen was negative in eight patients and showed a cyst in the head of pancreas in one patient. Extended distal (80%) pancreatectomy was performed in all nine patients. The procedure was attempted laparoscopically in eight patients but was converted to open in three. One patient had an open procedure from start to finish. Pathology showed changes compatible with nesidioblastosis with varying degrees of hyperplasia of islets and islet cells. Follow-up ranged from 8–54 (median, 22) months. All patients initially reported marked relief of symptoms. Over time, two patients had complete resolution of symptoms; three patients developed occasional symptoms (once or twice per month), which did not require any medication; two patients developed more frequent symptoms (more than twice per month), which were controlled with medications; and two patients had severe symptoms refractory to medical therapy (calcium channel blockers, diazoxide, octreotide).


Postprandial hypoglycemia after gastric bypass surgery with endogenous hyperinsulinemia is being increasingly recognized and reported in the literature. Our experience with nine patients is one of the largest. The etiology of this condition is not entirely understood. There may be yet unknown factors involved but increased secretion of glucagon-like peptide 1 and decreased grehlin are being implicated in islet cell hypertrophy. There is no “gold standard” treatment—medical or surgical—but distal pancreatectomy to debulk the hypertrophic islets and islet cells is the main surgical modality in patients with severe symptoms refractory to medical management.


Islet cell hyperplasia Nesidioblastosis Postgastric bypass Noninsulinoma pancreatogenous hypoglycemia 


  1. 1.
    Service FJ, Natt N, Thompson GB, Grant CS, van Heerden JA, Andrews JC, Lorenz E, Terzic A, Lloyd RV (1999) Non-insulinoma pancreatogenous hypoglycemia: a novel syndrome of hyperinsulinemic hypoglycemia in adults independent of mutations in Kir 6. 2 and SUR 1 genes. J Clin Endocrinol Metab 84(5):1582–1589CrossRefPubMedGoogle Scholar
  2. 2.
    Thompson GB, Service FJ, Andrews JC, Lloyd RV, Natt N, van Heerden JA, Grant CS (2000) Noninsulinoma pancreatogenous hypoglycemia syndrome: an update in 10 surgically treated patients. Surgery 128:937–944CrossRefPubMedGoogle Scholar
  3. 3.
    Anlauf M, Wieben D, Perren A, Sipos B, Komminoth P, Raffel A, Kruse ML, Fottner C, Knoefel WT, Monig H, Heitz PU, Kloppel G (2005) Persistent hyperinsulinemic hypoglycemia in 15 adults with diffuse nesidioblastosis: diagnostic criteria, incidence, and characterization of beta-cell changes. Am J Pathol 29(4):524–533CrossRefGoogle Scholar
  4. 4.
    Service GJ, Thompson GB, Service FJ, Andrews JC, Collazo-Clavell ML, Lloyd RV (2005) Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery. N Engl J Med 353:249–254CrossRefPubMedGoogle Scholar
  5. 5.
    Patti ME, McMahon G, Mun EC, Bitton A, Holst JJ, Goldsmith J, Hanto DW, Callery M, Arky R, Nose V, Bonner-Weir S, Goldfine AB (2005) Severe hypoglycaemia post-gastric bypass requiring partial pancreatectomy: evidence for inappropriate insulin secretion and pancreatic islet hyperplasia. Diabetologia 48:2236–2240CrossRefPubMedGoogle Scholar
  6. 6.
    Clancy TE, Moore FD Jr, Zinner MJ (2006) Post-gastric bypass hyperinsulinism with nesidioblastosis: subtotal or total pancreatectomy may be needed to prevent recurrent hypoglycemia. J Gastrointest Surg 10:1116–1119CrossRefPubMedGoogle Scholar
  7. 7.
    Miholic JC, Orskov JJ, Holst JJ, Kotzerke J, Meyer HJ (1991) Emptying of the gastric substitute, glucagon-like peptide-1 (GLP-1), and reactive hypoglycemia after total gastrectomy. Dig Dis Sci 36:1361–1370CrossRefPubMedGoogle Scholar
  8. 8.
    Andreasen JJ, Orskov C, Holst JJ (1994) Secretion of glucagon-like peptide-1 and reactive hypoglycemia after partial gastrectomy. Digestion 55:221–228CrossRefPubMedGoogle Scholar
  9. 9.
    Tritos NA, Mun E, Bertkau A, Grayson R, Maratos-Flier E, Goldfine A (2003) Serum ghrelin levels in response to glucose load in obese subjects post-gastric bypass surgery. Obes Res 11:919–924CrossRefPubMedGoogle Scholar
  10. 10.
    Korner J, Bessler M, Cirilo LJ, Conwell IM, Daud A, Restuccia NL, Wardlow SL (2005) Effects of Roux-en-Y gastric bypass surgery on fasting and postprandial concentrations of plasma ghrelin, peptide YY, and insulin. J Clin Endocrinol Metab 90:359–365CrossRefPubMedGoogle Scholar
  11. 11.
    Chan JL, Mun EC, Stoyneva V, Mantzoros CS, Goldfine AB (2006) Peptide YY levels are elevated after gastric bypass surgery. Obesity (Silver Spring) 14:194–198CrossRefGoogle Scholar
  12. 12.
    Pratt JS, Cummings S, Vineberg DA, Graeme-Cook F, Kaplan LM (2004) Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 25–2004. A 49-year-old woman with severe obesity, diabetes, and hypertension. N Engl J Med 351:696–705CrossRefPubMedGoogle Scholar
  13. 13.
    Crookes PF (2006) Surgical treatment of morbid obesity. Annu Rev Med 57:243–264CrossRefPubMedGoogle Scholar
  14. 14.
    Laidlaw GF (1938) Nesidioblastoma, the islet tumor of the pancreas. Am J Pathol 14:125–134PubMedGoogle Scholar
  15. 15.
    Yokovac WC, Baker L, Hummler K (1971) Beta cell nesidioblastosis in idiopathic hypoglycemia of infancy. Pediatrics 79:226–231CrossRefGoogle Scholar
  16. 16.
    Sandler R, Horwitz DL, Rubenstein AH, Kuzuya H (1975) Hypoglycemia and endogenous hyperinsulinism complicating diabetes mellitus. Application of the C-peptide assay to diagnosis and therapy. Am J Med 59:730–736CrossRefPubMedGoogle Scholar
  17. 17.
    Harness JK, Geelhoed GW, Thompson NW, Nishiyama RH, Fajans SS, Kraft RO, Howard DR, Clark KA (1981) Nesidioblastosis in adults. A surgical dilemma. Arch Surg 116(5):575–580PubMedGoogle Scholar
  18. 18.
    Fajans SS, Floyd JC Jr (1976) Fasting hypoglycemia in adults. N Engl J Med 294:766–772CrossRefPubMedGoogle Scholar
  19. 19.
    Alvarez GC, Faria EN, Beck M, Girardon DT, Machado AC (2007) Laparoscopic spleen-preserving distal pancreatectomy as treatment for nesidioblastosis after gastric bypass surgery. Obes Surg 17(4):550–552CrossRefPubMedGoogle Scholar
  20. 20.
    Buteau J, Foisy S, Joly E, Prentki M (2003) Glucagon-like peptide 1 induces pancreatic beta cell proliferation via transactivation of the epidermal growth factor receptor. Diabetes 52:124–132CrossRefPubMedGoogle Scholar
  21. 21.
    Farilla L, Bulotta A, Hirshberg B, Li Calzi S, Khoury N, Noushmehr H, Bertolotto C, Di Mario U, Harlan DM, Perfetti R (2003) Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets. Endocrinology 144:5149–5158CrossRefPubMedGoogle Scholar
  22. 22.
    Meier JJ, Butler AE, Galasso R, Butler PC (2006) Hyperinsulinemic hypoglycemia after gastric bypass surgery is not accompanied by islet hyperplasia or increased beta-cell turnover. Diabetes Care 29:1554–1559CrossRefPubMedGoogle Scholar
  23. 23.
    Witteles RM, Straus FH II, Sugg SL, Koka MR, Costa EA, Kaplan EL (2001) Adult-onset nesidioblastosis causing hypoglycemia: an important clinical entity and continuing treatment dilemma. Arch Surg 136:656–663CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Viney K. Mathavan
    • 1
  • Maurice Arregui
    • 1
  • Chad Davis
    • 1
  • Kirpal Singh
    • 1
  • Anand Patel
    • 1
  • James Meacham
    • 2
  1. 1.Department of SurgerySt Vincent HospitalIndianapolisUSA
  2. 2.Clarian Diabetes and EndocrinologyIndianapolisUSA

Personalised recommendations